Reopening America

Merck Seeks Authorization for Covid-19 Pill, First Oral Antiviral to Treat Coronavirus

Pharmaceutical company Merck is seeking emergency use authorization for its Covid-19 pill. If approved, it would be the first oral antiviral for Covid. Other treatments such as remdesivir and monoclonal antibody treatments both require an intravenous infusion. The pill reduces risk of hospitalization by 50%. Riley Griffin, healthcare reporter at Bloomberg News, joins us for more on this pill that directly targets the virus. Learn more about your ad-choices at <a href="https://www.iheartpodcastnetwork.com">https://www.iheartpodcastnetwork.com</a>See <a href="https://omnystudio.com/listener">omnystudio.com/listener</a> for privacy information.

We have shifted into a new phase in the coronavirus pandemic. We are social distancing, washing our hands, wearing face masks, and we are Reopening America. Oscar Ramirez from the Daily Dive Podcast updates you on any new information about the virus and vaccine development, but will focus on how cities, states, and industries affected by the shutdown are opening back up.